Իսրայել - եբրայերեն - Ministry of Health

takeda israel ltd - pantoprazole - טבליה - pantoprazole 40 mg - pantoprazole - pantoprazole - short term treatment of acute duodenal ulcer. acute gastric ulcer. moderate and severe reflux esophagitis. eradication of helicobacter pylori in combination with clarithromycin and amoxycillin or clarithromycin and metronidazole or amoxycillin and metronidazole in cases of duodenal ulcer and gastric ulcer with the objective of reducing of duodenal and gastric ulcers caused by this microorganism. zollinger ellison syndrome.

Իսրայել - եբրայերեն - Ministry of Health

cts chemical industries ltd, israel - famotidine - טבליה - famotidine 20 mg - famotidine - famotidine - treatment of duodenal ulcer. prevention of relapses of duodenal ulceration. treatment of benign gastric ulcer. pathological hypersecretory conditions such as zollinger-syndrome. gastroesophageal reflux disease.

Իսրայել - եբրայերեն - Ministry of Health

cts chemical industries ltd, israel - famotidine - טבליה - famotidine 40 mg - famotidine - famotidine - treatment of duodenal ulcer. prevention of relapses of duodenal ulceration. treatment of benign gastric ulcer. pathological hypersecretory conditions such as zollinger-syndrome. gastroesophageal reflux disease.

Իսրայել - եբրայերեն - Ministry of Health

dexcel ltd, israel - omeprazole - קפליות - omeprazole 20 mg - omeprazole - omeprazole - acute duodenal ulcer. acute gastric ulcer. reflux esophagitis: treatment , long - term management. maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. maintenance treatment for the prevention of relapse in patients with poorly reponsive peptic ulcer. zollinger-ellison syndrome. treatment and prevention of nsaid-associated duodenal and gastric ulcers or erosions in high risk patients. treatment of severe reflux oesophagitis in children overthe age of 6 year. helicobacter pylori - associated peptic ulcer disease in combination with antibiotics.

Իսրայել - եբրայերեն - Ministry of Health

dexcel ltd, israel - omeprazole - קפליות - omeprazole 40 mg - omeprazole - omeprazole - acute duodenal ulcer. acute gastric ulcer. reflux esophagitis: treatment , long - term management. maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. maintenance treatment for the prevention of relapse in patients with poorly reponsive peptic ulcer. zollinger-ellison syndrome. treatment and prevention of nsaid-associated duodenal and gastric ulcers or erosions in high risk patients. treatment of severe reflux oesophagitis in children overthe age of 6 year.helicobacter pylori - associated peptic ulcer disease in combination with antibiotics.

Իսրայել - եբրայերեն - Ministry of Health

dexcel ltd, israel - omeprazole - קפליות - omeprazole 10 mg - omeprazole - omeprazole - acute duodenal ulcer. acute gastric ulcer. reflux esophagitis: treatment , long - term management. maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. maintenance treatment for the prevention of relapse in patients with poorly reponsive peptic ulcer. zollinger-ellison syndrome. treatment and prevention of nsaid-associated duodenal and gastric ulcers or erosions in high risk patients. treatment of severe reflux oesophagitis in children overthe age of 6 year. helicobacter pylori - associated peptic ulcer disease in combination with antibiotics.

Իսրայել - եբրայերեն - Ministry of Health

rafa laboratories ltd - omeprazole 10 mg - capsules - omeprazole - acute duodenal ulcer, acute gastric ulcer, helicobacter pylori associated peptic ulcer disease in combination with antibiotics. reflux esophagitis: treatment long-term management, maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. treatment of severe reflux esophagitis in children from one year of age and older. maintenance treatment for the prevention of relapse in patients with poorly reponsive peptic ulcer. zollinger-ellison syndrome. treatment and prevention of nsaid-associated duodenal and gastric ulcer or erosions in high risk patients.

Իսրայել - եբրայերեն - Ministry of Health

rafa laboratories ltd - omeprazole - קפסולות - omeprazole 20 mg - omeprazole - omeprazole - acute duodenal ulcer, acute gastric ulcer, helicobacter pylori associated peptic ulcer disease in combination with antibiotics. reflux esophagitis: treatment long-term management, maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. treatment of severe reflux esophagitis in children from one year of age and older. maintenance treatment for the prevention of relapse in patients with poorly responsive peptic ulcer. zollinger-ellison syndrome. treatment and prevention of nsaid-associated duodenal and gastric ulcer or erosions in high risk patients.

Իսրայել - եբրայերեն - Ministry of Health

taro international ltd, israel - esomeprazole - טבליה - esomeprazole 20 mg - esomeprazole - esomeprazole - nexium tablets are indicated for: gastroesophageal reflux disease (gerd): - treatment of erosive reflux esophagitis - long-term management of patients with healed esophagitis to prevent relapse - symptomatic treatment of gastroesophageal reflux disease (gerd). in combination with an appropriate antibacterial therapeutic regimen for the eradication of helicobacter pylori and: - healing of helicobacter pylori associated duodenal ulcer and - prevention of relapse of peptic ulcers in patients with helicobacter pylory associated ulcers. - healing of gastric ulcers associated with nsaid therapy. - prevention of gastric and duodenal ulcers associated with nsaid therapy in patients at risk.prolonged treatment after i.v induced prevention of rebleeding of peptic ulcers.

Իսրայել - եբրայերեն - Ministry of Health

astrazeneca (israel) ltd - esomeprazole - טבליה - esomeprazole 20 mg - esomeprazole - esomeprazole - nexium tablets are indicated for: gastroesophageal reflux disease (gerd): - treatment of erosive reflux esophagitis - long-term management of patients with healed esophagitis to prevent relapse - symptomatic treatment of gastroesophageal reflux disease (gerd). in combination with an appropriate antibacterial therapeutic regimen for the eradication of helicobacter pylori and: - healing of helicobacter pylori associated duodenal ulcer and - prevention of relapse of peptic ulcers in patients with helicobacter pylory associated ulcers. - healing of gastric ulcers associated with nsaid therapy. - prevention of gastric and duodenal ulcers associated with nsaid therapy in patients at risk.prolonged treatment after i.v induced prevention of rebleeding of peptic ulcers.